Allergan Trademark Details
Word Mark | Allergan |
---|---|
Status | Alive 730 — First Extension - Granted |
Serial Number | 86661138 |
---|---|
Status Date | Wednesday, September 14, 2016 |
Filing Date | Wednesday, September 14, 2016 |
Correspondent
SUSAN J. HINCHEY
Allergan
2525 DuPont Dr
Irvine, CA 92612-1599
Allergan
2525 DuPont Dr
Irvine, CA 92612-1599
Case File Statements
Indication of Colors | The color(s) dark blue, medium blue, light blue, green, medium green, and yellow is/are claimed as a feature of the mark. |
---|---|
Description of Mark | The mark consists of the word "ALLERGAN" in a stylized dark blue font to the left of which is a stylized futuristic comet design comprised of circles that are as follows moving from right to left: three large dark blue circles, followed next by four medium blue circles that are large on the outside with the two middle circles being smaller, followed next by three small light blue circles, followed next by three large green circles, followed next by three smaller medium green circles, followed next by three small yellow circles, with the last circle being the point of the comet. |
Goods & Services | House mark used for a line of cosmetic and skin soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth |
Goods & Services | House mark used for a line of pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations, and pharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body; medicated cosmetic skin care preparations |
Goods & Services | House mark used for a line of surgical, medical, dental and veterinary apparatus and instruments, namely, diagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for use in facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics and ophthalmic related diseases and disorders |
Classifications
International Class Codes |
003
|
---|---|
U.S. Class Codes | 001, 004, 006, 050, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, June 17, 2015 |
Primary Code | 003 |
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, June 17, 2015 |
Primary Code | 005 |
International Class Codes |
010
|
---|---|
U.S. Class Codes | 026, 039, 044 |
Status | 6 — Active |
Status Date | Wednesday, June 17, 2015 |
Primary Code | 010 |
Trademark Timeline
-
Jun 12 2015Trademark application filed with USPTO
-
Jun 16 2015New Application Entered In Tram
-
Jun 17 2015New Application Office Supplied Data Entered In Tram
-
Jun 18 2015Notice of Design Search Code E-Mailed
-
Sep 22 2015Notification of Priority Action E-Mailed
-
Sep 22 2015Priority Action E-Mailed
-
Sep 22 2015Priority Action Written
-
Sep 22 2015Assigned To Examiner
-
Jan 19 2016Correspondence Received In Law Office
-
Jan 19 2016Teas Response To Office Action Received
-
Jan 20 2016Teas/email Correspondence Entered
-
Jan 22 2016Approved For Pub - Principal Register
-
Jan 22 2016Examiner's Amendment Entered
-
Jan 22 2016Notification of Examiners Amendment E-Mailed
-
Jan 22 2016Examiners Amendment E-Mailed
-
Jan 22 2016Examiners Amendment -Written
-
Feb 10 2016Notification of Notice of Publication E-Mailed
-
Mar 01 2016Official Gazette Publication Confirmation E-Mailed
-
Mar 01 2016Published For Opposition
-
Apr 26 2016Noa E-Mailed - Sou Required From Applicant
-
Sep 14 2016Extension 1 Granted
-
Sep 14 2016Extension 1 Filed
-
Sep 14 2016Teas Extension Received
-
Sep 16 2016Notice of Approval of Extension Request E-Mailed